血蛋白和炎症性肠道疾病的风险:一个双样本的门德尔随机化研究
Zheng Jiao1, Ge-Ge Li2, Ling-Shuo Bai3
1Department of Internal Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Medicine
|October 15, 2025
概括
这项研究使用了门德尔的随机化来发现血蛋白和炎症性肠病 (IBD) 之间的因果关系. 五种蛋白质,包括红细胞带7和IL1RL1,与IBD风险有关,提供了新的治疗点.
科学领域:
- 遗传学和分子生物学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 是一个重大的全球健康挑战.
- 失调的血蛋白是IBD的潜在治疗点.
- 目前对于这些蛋白质-IBD关联存在有限的因果关系证据.
研究的目的:
- 研究基因预测血蛋白水平与IBD发展风险之间的因果关系.
- 确定可能作为IBD亚型,克罗恩病 (CD) 和性结肠炎 (UC) 的新疗法点的特定血蛋白.
主要方法:
- 孟德尔随机化 (MR) 分析是使用遗传仪器对3282种血蛋白表型进行的.
- 分析了整体IBD,CD和UC的全基因组关联研究 (GWAS) 总结统计数据.
- 逆变量加权 (IVW) 回归被用于估计几率比率 (OR) 和95%置信区间 (CI).
主要成果:
- 四种蛋白质与整体IBD风险有着明显的关联:红细胞带 7 整体膜蛋白,介质素-1 类似受体 1 (IL1RL1),介质素-18 受体 1 (IL18R1) 和酒精脱酶 1 B (ADH1B).
- 疾病发病风险与红细胞带7和IL1RL1.1特别相关.
- 结核病风险与ADH1B和高亲和性免疫球蛋白马Fc受体I (FCGR1A) 有关.
结论:
- 这项MR研究确定了特定的血蛋白 (红细胞带7,IL1RL1,IL18R1,ADH1B,FCGR1A) 和IBD病原体之间的因果关系.
- 鉴定了CD和UC的不同蛋白质配置,这表明了不同的潜在分子机制.
- 这些发现暗示着先天免疫和代谢途径的失调,为未来IBD治疗开发提供了机制性见解.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Inflammatory Bowel Disease I: Ulcerative Colitis
894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
Inflammatory Bowel Disease II: Crohn's Disease
952
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
952
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Drug Distribution: Plasma Protein Binding
8.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.5K


